New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Potential therapy for treatment-resistant hypothyroidism proves effective in lab study

Potential therapy for treatment-resistant hypothyroidism proves effective in lab study

byRush University Medical CenterA new "metal-coordinated" drug-delivery technology potentially could be used to supplement the standard therapy for hypothyroidism, which affects nearly
Diabetes & Endocrinology December 18,2023
Potential therapy for treatment-resistant hypothyroidism proves effective in lab study

Potential therapy for treatment-resistant hypothyroidism proves effective in lab study

byRush University Medical CenterA new "metal-coordinated" drug-delivery technology potentially could be used to supplement the standard therapy for hypothyroidism, which affects nearly
Diabetes & Endocrinology December 18,2023
HPV blood test shows promise for tracking head and neck cancer after treatment

HPV blood test shows promise for tracking head and neck cancer after treatment

byUNC Lineberger Comprehensive Cancer CenterA new blood test developed by University of North Carolina Lineberger Comprehensive Cancer Center researchers shows promise for tracking HPV-linked he
Oncology December 18,2023
HPV blood test shows promise for tracking head and neck cancer after treatment

HPV blood test shows promise for tracking head and neck cancer after treatment

byUNC Lineberger Comprehensive Cancer CenterA new blood test developed by University of North Carolina Lineberger Comprehensive Cancer Center researchers shows promise for tracking HPV-linked he
Oncology December 18,2023
How cancer cells move and metastasize is influenced by the fluids surrounding them

How cancer cells move and metastasize is influenced by the fluids surrounding them

by Yizeng Li,The ConversationCredit: CC0 Public DomainCell migration, or how cells move in the body, is essential to both normal body function and disease progression. Cell movement is what allo
Oncology December 18,2023
How cancer cells move and metastasize is influenced by the fluids surrounding them

How cancer cells move and metastasize is influenced by the fluids surrounding them

by Yizeng Li,The ConversationCredit: CC0 Public DomainCell migration, or how cells move in the body, is essential to both normal body function and disease progression. Cell movement is what allo
Oncology December 18,2023
High-dose, high-precision radiation therapy safe, effective for solitary kidney cancer patients with only one kidney

High-dose, high-precision radiation therapy safe, effective for solitary kidney cancer patients with only one kidney

byAmerican Society for Radiation OncologyTreatment of renal cell carcinoma with stereotactic radiation therapy is as safe and effective for patients with one kidney as it is for those who have t
Oncology December 18,2023
High-dose, high-precision radiation therapy safe, effective for solitary kidney cancer patients with only one kidney

High-dose, high-precision radiation therapy safe, effective for solitary kidney cancer patients with only one kidney

byAmerican Society for Radiation OncologyTreatment of renal cell carcinoma with stereotactic radiation therapy is as safe and effective for patients with one kidney as it is for those who have t
Oncology December 18,2023
Women more prone to selected oesophagogastric cancer chemotherapy side-effects

Women more prone to selected oesophagogastric cancer chemotherapy side-effects

byEuropean Society for Medical OncologyMen and women may need to be treated differently—at least when it comes to some types of cancer. In an analysis (1) to be presented at the ESMO 2018 Congre
Oncology December 18,2023
Women more prone to selected oesophagogastric cancer chemotherapy side-effects

Women more prone to selected oesophagogastric cancer chemotherapy side-effects

byEuropean Society for Medical OncologyMen and women may need to be treated differently—at least when it comes to some types of cancer. In an analysis (1) to be presented at the ESMO 2018 Congre
Oncology December 18,2023
Weight loss surgery for obese women prevents womb cancer

Weight loss surgery for obese women prevents womb cancer

by Mike Addelman,University of ManchesterA study of women who had gastric sleeve or bypass surgery for obesity has found that precancerous tissue in their womb reverted to normal tissue when the
Oncology December 18,2023
Weight loss surgery for obese women prevents womb cancer

Weight loss surgery for obese women prevents womb cancer

by Mike Addelman,University of ManchesterA study of women who had gastric sleeve or bypass surgery for obesity has found that precancerous tissue in their womb reverted to normal tissue when the
Oncology December 18,2023
Local radiotherapy improves survival in metastatic prostate cancer with low disease burden

Local radiotherapy improves survival in metastatic prostate cancer with low disease burden

byEuropean Society for Medical OncologyRadiotherapy to the prostate improves overall survival in men newly diagnosed with metastatic prostate cancer who have a low metastatic disease burden but
Oncology December 18,2023
Local radiotherapy improves survival in metastatic prostate cancer with low disease burden

Local radiotherapy improves survival in metastatic prostate cancer with low disease burden

byEuropean Society for Medical OncologyRadiotherapy to the prostate improves overall survival in men newly diagnosed with metastatic prostate cancer who have a low metastatic disease burden but
Oncology December 18,2023
Cancer cells may shrink or super-size to survive

Cancer cells may shrink or super-size to survive

byInstitute of Cancer ResearchCredit: Pixabay/CC0 Public DomainCancer cells can shrink or super-size themselves to survive drug treatment or other challenges within their environment, researcher
Oncology December 18,2023
Cancer cells may shrink or super-size to survive

Cancer cells may shrink or super-size to survive

byInstitute of Cancer ResearchCredit: Pixabay/CC0 Public DomainCancer cells can shrink or super-size themselves to survive drug treatment or other challenges within their environment, researcher
Oncology December 18,2023
Radiation therapy outcomes better for African-American than Caucasian prostate cancer patients

Radiation therapy outcomes better for African-American than Caucasian prostate cancer patients

byAmerican Society for Radiation OncologyWhile popular beliefs and population data suggest that African-American men are at higher risk of dying from prostate cancer than Caucasian men, a new an
Oncology December 18,2023
Radiation therapy outcomes better for African-American than Caucasian prostate cancer patients

Radiation therapy outcomes better for African-American than Caucasian prostate cancer patients

byAmerican Society for Radiation OncologyWhile popular beliefs and population data suggest that African-American men are at higher risk of dying from prostate cancer than Caucasian men, a new an
Oncology December 18,2023
Huge variations between countries in time for reimbursement decisions on new cancer drugs

Huge variations between countries in time for reimbursement decisions on new cancer drugs

byEuropean Society for Medical OncologySome European countries take more than twice as long as others to reach health technology assessment (HTA) decisions to reimburse new cancer drugs followin
Oncology December 18,2023
Huge variations between countries in time for reimbursement decisions on new cancer drugs

Huge variations between countries in time for reimbursement decisions on new cancer drugs

byEuropean Society for Medical OncologySome European countries take more than twice as long as others to reach health technology assessment (HTA) decisions to reimburse new cancer drugs followin
Oncology December 18,2023
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com